Exhibit 99.1
AMARIN APPOINTS JONATHAN PROVOOST EXECUTIVE VICE PRESIDENT, CHIEF LEGAL & COMPLIANCE OFFICER
Provoost Brings More than 20 Years of Corporate Counsel Experience to Amarin |
DUBLIN, Ireland and BRIDGEWATER, N.J., OCTOBER 31, 2023 Amarin Corporation plc (NASDAQ:AMRN) today announced the appointment
of Jonathan Provoost as the Companys new Executive Vice President, Chief Legal & Compliance Officer. He will join the Company on November 15.
Mr. Provoost, who most recently served as Vice President, General Counsel and Chief Compliance Officer at Tris Pharma, Inc., brings more than 20 years of
corporate legal experience, having served most of his career in large and medium-sized pharmaceutical companies.
We are excited to welcome Jonathan to Amarin, where he will serve as an integral part of our leadership team and will be responsible for helping define
and execute our ongoing legal and compliance strategy to support our key priorities, said Patrick Holt, President & CEO, Amarin. Jonathans depth of experience with corporate and compliance matters, as well former
leadership roles managing intellectual property, complex litigation, business development and transactional matters, will provide the right mix of capabilities to help support Amarin and our future path.
Mr. Provoosts broad experience in the legal profession includes serving as Chief Compliance Officer and General Counsel, management of intellectual
property, general transactions, litigation, and various business activities. Throughout Jonathans career he has enjoyed positions of increasing managerial responsibility, and most recently, served as Vice President, General Counsel and Chief
Compliance Officer at Tris Pharma, Inc. Prior to Tris, Jonathan served as General Counsel for Business Development & Licensing at Mallinckrodt Pharmaceuticals following a number of roles of increasing responsibility at the company. Earlier
in his career, Mr. Provoost served in various legal roles for other pharmaceutical companies, including Ikaria, Inc., Kos Pharmaceuticals and Bristol-Myers Squibb. Jonathan earned his J.D. from Pace University School of Law, his M.B.A. from
Lehigh University, and a B.S. in Chemistry from SUNY Oswego, in addition to serving in the U.S. Marine Corps Reserve. He is admitted to NY/NJ bars and is registered to practice before the U.S. Patent and Trademark Office (USPTO).